Cargando…

血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295620/
https://www.ncbi.nlm.nih.gov/pubmed/34384163
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.016
_version_ 1783725469365960704
collection PubMed
description
format Online
Article
Text
id pubmed-8295620
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-82956202021-08-23 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例 Zhonghua Xue Ye Xue Za Zhi 病例报告 Editorial office of Chinese Journal of Hematology 2021-06 /pmc/articles/PMC8295620/ /pubmed/34384163 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.016 Text en 2021年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 病例报告
血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例
title 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例
title_full 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例
title_fullStr 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例
title_full_unstemmed 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例
title_short 血液透析成功解救MTHFR C677T基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例
title_sort 血液透析成功解救mthfr c677t基因阳性急性淋巴细胞白血病甲氨蝶呤高敏反应一例
topic 病例报告
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295620/
https://www.ncbi.nlm.nih.gov/pubmed/34384163
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.016
work_keys_str_mv AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì
AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì
AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì
AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì
AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì
AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì
AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì
AT xuèyètòuxīchénggōngjiějiùmthfrc677tjīyīnyángxìngjíxìnglínbāxìbāobáixuèbìngjiǎāndiélìnggāomǐnfǎnyīngyīlì